The prevalence of multiple sclerosis (MS) and the age of affected patients are increasing
owing to increased longevity of the general population and the availability of effective …

Introduction We present international consensus recommendations for improving diagnosis,
management and treatment access in multiple sclerosis (MS). Our vision is that these will be …

Objective To generate a national multiple sclerosis (MS) prevalence estimate for the United
States by applying a validated algorithm to multiple administrative health claims (AHC) …

Background Multiple sclerosis is the most common inflammatory neurological disease in
young adults. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) …

The Americas In 2007, Poser and Brinar 1 noted that published prevalence rates of multiple
sclerosis (MS) could be misleading with the reliance on clinical information and brain MRI …

Importance Racial, ethnic, and geographic differences in multiple sclerosis (MS) are
important factors to assess when determining the disease burden and allocating health care …

Background Multiple sclerosis (MS) is the most common cause of neurological disability in
young adults worldwide and approximately half of those affected are in Europe. The …

Background: Comorbidity is an area of increasing interest in multiple sclerosis (MS).
Objective: The objective of this review is to estimate the incidence and prevalence of …

Objective: To estimate the US commercially insured multiple sclerosis (MS) annual
prevalence from 2008 to 2012. Methods: The study was a retrospective analysis using …

Objective: We aimed to compare survival in the multiple sclerosis (MS) population with a
matched cohort from the general population, and to evaluate the association of comorbidity …